Clinical Trial Update: The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial of the AttenueX IntraVesical System for stress urinary incontinence has completed, according to the update from Solace Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• AttenueX IntraVesical System

Snippet

Sponsor: Solace Therapeutics, Inc. | Conditions: Urinary Incontinence, Stress | Phase 3 | Status: COMPLETED